Zymenex A/S

ACTIVE

Denmarkwww.zymenex.comSubsidiary11–50 employeesEstablished: 1998-01-01

Part of zymenex holding a/s

Clinical Trials

14 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

1998

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

18.2%

Phase 2

13.6%

Phase 3

9.1%

Trial Status Distribution

Active, not recruiting

63.6%

Completed

31.8%

Unknown

4.5%

Clinical Trials

Trials sponsored by this organization (22)

A trial of the long-term safety of Lamazym aftercare treatment of subjects with alpha-Mannosidosis who previously participated in Lamazym-trials

Phase 1

Active, not recruiting

Sep 20157 participants

Evaluation of Long-term Efficacy of Treatment With Lamazym

Phase 3

Completed

interventional

Feb 201518 participants

Medical research trial for testing drug treatment of alpha-Mannosidosis

Active, not recruiting

Nov 2014

A Placebo-Controlled phase 3 trial of repeated Lamazym treatment of subjects with Alpha-Mannosidosis

Active, not recruiting

Jun 201325 participants

A Placebo-Controlled phase 3 trial of repeated Lamazym treatment of subjects with Alpha-Mannosidosis

Phase 1

Active, not recruiting

Jan 201325 participants

A Placebo-Controlled phase 3 trial of repeated Lamazym treatment of subjects with Alpha-Mannosidosis

Active, not recruiting

Jan 201325 participants

A Placebo-Controlled phase 3 trial of repeated Lamazym treatment of subjects with Alpha-Mannosidosis

Active, not recruiting

Aug 201220 participants

A Placebo-Controlled Phase 3 Trial of Repeated Lamazym Treatment of Subjects With Alpha-Mannosidosis

Phase 3

Completed

interventional

Aug 201225 participants

Page 1 of 3

Approvals

No approval data available

News

No news articles found

Back to Organizations